Challenging the effectiveness of green tea in primary and tertiary cancer prevention

PurposeDrinking green tea daily is part of Japanese culture, and various studies have revealed that green tea is a cancer preventive. We here review our progress in cancer prevention with green tea on 12 main topics, from basic to clinical level.Topics and methodsBiochemical and biological studies of green tea catechins, a prospective cohort study, preclinical safety trials with tablets of green tea extract, double-blind randomized clinical phase II prevention trial for recurrence of colorectal adenomas, and synergistically enhanced inhibition by the combination of green tea catechins and anticancer drugs. All results were significant, including human studies with informed consent.ResultsDrinking 10 Japanese-size cups of green tea per day delayed the cancer onset of humans 7 years for females. For tertiary cancer prevention, consuming 10 cups of green tea per day fortified by green tea tablets, 50 %, significantly prevented the recurrence of colorectal adenomas. A minimum effective amount of green tea catechins for cancer prevention was found in humans. In addition, the combination of green tea catechins and anticancer drugs engendered a new cancer therapeutic strategy.ConclusionThe consumption of 10 Japanese-size cups of green tea per day is a significant factor in primary cancer prevention for the general population, and the preventive effect on recurrence of colorectal adenomas in patients is vital evidence in tertiary cancer prevention.

[1]  T. Sugimura,et al.  Antitumor promoting activity of (−)‐epigallocatechin gallate, the main constituent of “Tannin” in green tea , 1987 .

[2]  T. Okuda,et al.  Inhibitory effect of tannins on direct-acting mutagens. , 1984, Chemical & pharmaceutical bulletin.

[3]  G. Yang,et al.  Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. , 1998, Carcinogenesis.

[4]  K. Nakachi,et al.  Cancer-preventive effects of drinking green tea among a Japanese population. , 1997, Preventive medicine.

[5]  Y. Nishino,et al.  Green tea and the risk of gastric cancer in Japan. , 2001, The New England journal of medicine.

[6]  A. Komori,et al.  Japanese green tea as a cancer preventive in humans. , 2009, Nutrition reviews.

[7]  Hideyuki Ito,et al.  Wide distribution of [3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. , 1998, Carcinogenesis.

[8]  K. Michels,et al.  Green tea consumption and breast cancer risk or recurrence: a meta-analysis , 2009, Breast Cancer Research and Treatment.

[9]  G. Bowden,et al.  Inhibition of ultraviolet B–induced c‐fos gene expression and p38 mitogen‐activated protein kinase activation by (‐)‐epigallocatechin gallate in a human keratinocyte cell line , 1999, Molecular carcinogenesis.

[10]  Y. Ohkura,et al.  Combination cancer chemoprevention with green tea extract and sulindac shown in intestinal tumor formation in Min mice , 2001, Journal of Cancer Research and Clinical Oncology.

[11]  Helgi I. Ingólfsson,et al.  The inhibitory effect of (-)-epigallocatechin gallate on activation of the epidermal growth factor receptor is associated with altered lipid order in HT29 colon cancer cells. , 2007, Cancer research.

[12]  Z. Y. Wang,et al.  Tea and cancer. , 1993, Journal of the National Cancer Institute.

[13]  H. Fujiki,et al.  A New Function of Green Tea: Prevention of Lifestyle‐related Diseases , 2001, Annals of the New York Academy of Sciences.

[14]  Clinical development plan: Tea extracts green tea polyphenols epigallocatechin gallate , 2002 .

[15]  K. Wakamatsu,et al.  Okadaic acid: an additional non-phorbol-12-tetradecanoate-13-acetate-type tumor promoter. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[16]  김은정,et al.  Epigallocatechin gallate , 2013, Reactions Weekly.

[17]  Mujo Kim,et al.  Inhibition of Azoxymethane‐induced Colon Carcinogenesis in Rat by Green Tea Polyphenol Fraction , 1991, Japanese journal of cancer research : Gann.

[18]  H. Fujiki,et al.  Inhibition of N-methyl-N'-nitro-N-nitrosoguanidine-induced carcinogenesis by (-)-epigallocatechin gallate in the rat glandular stomach. , 1995, Cancer research.

[19]  M. Marino,et al.  Essential role of tumor necrosis factor alpha (TNF-alpha) in tumor promotion as revealed by TNF-alpha-deficient mice. , 1999, Cancer research.

[20]  Keunchil Park,et al.  Mechanistic Aspects of Green Tea as a Cancer Preventive: Effect of Components on Human Stomach Cancer Cell Lines , 1999, Japanese journal of cancer research : Gann.

[21]  T. Okuda,et al.  Relationship of the structures of tannins to the binding activities with hemoglobin and methylene blue. , 1985, Chemical & pharmaceutical bulletin.

[22]  A. Komori,et al.  Mechanisms of Growth Inhibition of Human Lung Cancer Cell Line, PC‐9, by Tea Polyphenols , 1997, Japanese journal of cancer research : Gann.

[23]  Kaori Suzuki,et al.  Green tea polyphenol stimulates cancer preventive effects of celecoxib in human lung cancer cells by upregulation of GADD153 gene , 2006, International Journal of Cancer.

[24]  M. Shimizu,et al.  Green Tea Extracts for the Prevention of Metachronous Colorectal Adenomas: A Pilot Study , 2008, Cancer Epidemiology Biomarkers & Prevention.

[25]  Jun-yan Hong,et al.  Inhibition of N-nitrosodiethylamine- and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced tumorigenesis in A/J mice by green tea and black tea. , 1992, Cancer research.

[26]  Y. Higashi,et al.  Influence of Drinking Green Tea on Breast Cancer Malignancy among Japanese Patients , 1998, Japanese journal of cancer research : Gann.

[27]  H. Fujiki,et al.  Synergistic effects of (--)-epigallocatechin gallate with (--)-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9. , 1999, Cancer research.

[28]  Y. Muto,et al.  Penta-O-Galloyl-β-D-Glucose and (-)-Epigallocatechin Gallate: Cancer Preventive Agents , 1992 .

[29]  M. Hergenhahn,et al.  Irritant diterpene ester promoters of mouse skin: contributions to etiologies of environmental cancer and to biochemical mechanisms of carcinogenesis. , 1983, Princess Takamatsu symposia.

[30]  H. Fujiki,et al.  Modulation of gene expression by (-)-epigallocatechin gallate in PC-9 cells using a cDNA expression array. , 2001, Biological & pharmaceutical bulletin.

[31]  Kaori Suzuki,et al.  Carcinogenic potential of tobacco tar-resistant Staphylococcus aureus in buccal cavity , 2004, Journal of Cancer Research and Clinical Oncology.

[32]  M. Sporn,et al.  Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). , 1976, Federation proceedings.

[33]  C K Redmond,et al.  Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. , 1999, Journal of the National Cancer Institute.

[34]  T. Kuzuhara,et al.  DNA and RNA as New Binding Targets of Green Tea Catechins* , 2006, Journal of Biological Chemistry.

[35]  Y. Nakamura,et al.  Genetic alterations during colorectal-tumor development. , 1988, The New England journal of medicine.

[36]  R. Agarwal,et al.  Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. , 1997, Journal of the National Cancer Institute.

[37]  H. Fujiki,et al.  Green tea: cancer preventive beverage and/or drug. , 2002, Cancer letters.

[38]  Robert J Cersosimo,et al.  Tamoxifen for Prevention of Breast Cancer , 2003 .

[39]  H. Fujiki,et al.  Cancer prevention with green tea and monitoring by a new biomarker, hnRNP B1. , 2001, Mutation research.

[40]  Yi-Song Wang,et al.  WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. , 1994, Cancer research.

[41]  H. Fujiki,et al.  Tumor promoters--microcystin-LR, nodularin and TNF-α and human cancer development. , 2011, Anti-cancer agents in medicinal chemistry.

[42]  M. Suganuma,et al.  Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention. , 2000, BioFactors.

[43]  T. Kuzuhara,et al.  Synergistic effects of multiple treatments, and both DNA and RNA direct bindings on, green tea catechins , 2007, Molecular carcinogenesis.

[44]  Chung S. Yang,et al.  Green Tea and Cancer Prevention , 2010, Nutrition and Cancer.

[45]  A. Komori,et al.  Anticarcinogenic activity of green tea polyphenols. , 1993, Japanese journal of clinical oncology.

[46]  H. Fujiki.  Green tea: Health benefits as cancer preventive for humans. , 2005, Chemical record.

[47]  M. Masuda,et al.  Cancer chemoprevention with green tea catechins by targeting receptor tyrosine kinases. , 2011, Molecular nutrition & food research.

[48]  A. Komori,et al.  Tumor necrosis factor acts as a tumor promoter in BALB/3T3 cell transformation. , 1993, Cancer research.

[49]  Giovanni Castagnetti,et al.  Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. , 2006, Cancer research.

[50]  D. Ron,et al.  Feedback Inhibition of the Unfolded Protein Response by GADD34-Mediated Dephosphorylation of eIF2α , 2001, The Journal of cell biology.

[51]  T. Kuzuhara,et al.  Green tea catechin as a chemical chaperone in cancer prevention. , 2008, Cancer letters.

[52]  Achinto Saha,et al.  New cancer treatment strategy using combination of green tea catechins and anticancer drugs , 2011, Cancer science.

[53]  T. Kuzuhara,et al.  Helicobacter pylori-secreting protein Tipα is a potent inducer of chemokine gene expressions in stomach cancer cells , 2007, Journal of Cancer Research and Clinical Oncology.

[54]  Diane D. Liu,et al.  Phase II Randomized, Placebo-Controlled Trial of Green Tea Extract in Patients with High-Risk Oral Premalignant Lesions , 2009, Cancer Prevention Research.

[55]  W. Willett,et al.  Green tea drinking and subsequent risk of breast cancer in a population to based cohort of Japanese women , 2010, Breast Cancer Research.

[56]  Michael Karin,et al.  Inflammation meets cancer, with NF-κB as the matchmaker , 2011, Nature Immunology.

[57]  H. Fujiki.  Two stages of cancer prevention with green tea , 1999, Journal of Cancer Research and Clinical Oncology.

[58]  T. Narisawa,et al.  A Very Low Dose of Green Tea Polyphenols in Drinking Water Prevents N‐Methyl‐N‐nitrosourea‐induced Colon Carcinogenesis in F344 Rats , 1993, Japanese journal of cancer research : Gann.

[59]  J. Brockmöller,et al.  Protocol for MInimizing the Risk of Metachronous Adenomas of the CoLorectum with Green Tea Extract (MIRACLE): a randomised controlled trial of green tea extract versus placebo for nutriprevention of metachronous colon adenomas in the elderly population , 2011, BMC Cancer.

[60]  Y. Saeki,et al.  Discrete roles of cytokines, TNF-α, IL-1, IL-6 in tumor promotion and cell transformation , 2002 .

[61]  M. Kris,et al.  Phase I study of green tea extract in patients with advanced lung cancer , 2004, Cancer Chemotherapy and Pharmacology.

[62]  J. Lewin,et al.  Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[63]  H. Fujiki,et al.  Effect of (-)-epigallocatechin gallate, the main constituent of green tea, on lung metastasis with mouse B16 melanoma cell lines. , 1992, Cancer letters.

[64]  F. Khuri,et al.  Phase I trial of oral green tea extract in adult patients with solid tumors. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[65]  T. Okuda,et al.  Inhibitory Effect of (—)‐Epigallocatechin Gallate on Carcinogenesis with N‐Ethyl‐N′‐nitro‐N‐nitrosoguanidine in Mouse Duodenum , 1989, Japanese journal of cancer research : Gann.